CIK 0001174940 · Non-accelerated filer<br>Smaller reporting company
ORAGENICS INC
Sign in to watch- Ticker
- OGEN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 593410522
- Phone
- 8132867900
- Business address
- 9015 TOWN CENTER PARKWAY, SUITE 143, LAKEWOOD RANCH, FL, 34202
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Spencer John Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +55,900 | 55,900 | ||
| 2025-12-12 | Telling Fred Director | Sale | −210 | $0.94 | $198 | 948 |
| 2025-12-12 | Telling Fred Director | Sale | −210 | $0.94 | $198 | 34,538 |
| 2025-12-11 | Telling Fred Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-12-11 | Huffman Janet CEO and CFO | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2025-12-11 | Telling Fred Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-12-11 | Giordano Natasha Director | Grant or award · Non-Employee Director Option (Right to Buy) | +38,320 | 38,320 | ||
| 2025-12-11 | Giordano Natasha Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-12-11 | DUNTON ALAN W Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-12-11 | KOSKI ROBERT C Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-12-11 | GANDOLFO JOHN P Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-12-11 | POPE CHARLES L Director | Grant or award · Non-Employee Director Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-06-18 | Odyssey Health, Inc. 10% owner | Sale | −5,044 | $4.26 | $21K | 0 |
| 2025-06-17 | Odyssey Health, Inc. 10% owner | Sale | −2,000 | $4.46 | $9K | 5,044 |
| 2025-06-16 | Odyssey Health, Inc. 10% owner | Sale | −5,000 | $4.45 | $22K | 7,044 |
| 2025-06-13 | Odyssey Health, Inc. 10% owner | Sale | −5,000 | $4.27 | $21K | 12,044 |
| 2024-12-11 | KOSKI ROBERT C Director | Conversion | +5,000 | 23,367 | ||
| 2024-12-11 | KOSKI ROBERT C Director | Conversion · Series B Convertible Preferred Stock | −1,500,000 | 0 | ||
| 2024-12-06 | DUNTON ALAN W Director | Sale | −66 | $0.36 | $24 | 25,623 |
| 2024-12-06 | Telling Fred Director | Sale | −3,597 | $0.36 | $1K | 34,748 |
Page 1 of 7 · 130 trades